Vital Health Markers to Track During GLP-1 Medication Use
Stepping into a new medical plan with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) requires you to stay alert. These…
-
-
GLP-1 and SGLT2 Drugs Found Safe From Serious Infection Risk in Major Global Study
A major global study has delivered reassuring news for millions of people who take GLP-1 receptor agonists and SGLT2…
-
Potential for GLP-1 Therapy to Bridge the Mortality Gap in Mental Health
Modern medical breakthroughs are currently changing how we view the long-term health of psychiatric patients. This shift goes far…
-
New Research Reveals How GLP-1 Changes the Way We Taste Food
Modern medical studies are currently proving that our taste buds are closely tied to our metabolism. This discovery goes…
-
How Long Do You Stay on GLP-1 Pills?
Glucagon-like peptide-1 receptor agonists represent a major shift in metabolic healthcare. These drugs manage blood sugar and hunger signals…
-
FDA Delay Pushes Eli Lilly’s Oral Weight-Loss Pill to April, Shaking Investor Confidence
Eli Lilly’s experimental oral weight-loss drug orforglipron has encountered a regulatory delay, pushing back what investors hoped would be…
-
Diabetes Drugs Show Promise in Fighting Addiction and Boosting Mental Health
A new review in JAMA Psychiatry suggests that glucagon-like peptide-1 (GLP-1) therapies could offer hope for treating addiction and…
-
Weight Loss Reshapes Fat Cells and Restores Metabolic Health, Study Finds
Weight loss may do far more than reduce body weight. New research shows it can actively reshape fat tissue…
-
How GLP-1 Works in the Body: A Beginner-Friendly Guide
If you have spent any time following health news recently, you have likely heard about a breakthrough class of…
-
Oral GLP-1 Diabetes Therapy Shock: FDA Clears ASC30 for Human Trials
Ascletis Pharma Inc. announced a major step forward in diabetes therapy innovation. The Food and Drug Administration granted Investigational…
